Quarter Comparison
Revenue
Operating Income
Gross Margin
Net Margin
Income Statement
Cash Flow Statement
Balance Sheet
Earnings Release
EX-99.1 3 cv-20260813xex991q22026ear.htm EX-99.1 Document Exhibit 99.1 CapsoVision Reports Second Quarter 2026 Financial Results SARATOGA, Calif., August 13, 2026 - CapsoVision, Inc.
EX-99.1 3 cv-20260813xex991q22026ear.htm EX-99.1 Document Exhibit 99.1 CapsoVision Reports Second Quarter 2026 Financial Results SARATOGA, Calif., August 13, 2026 - CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results and provided a business update for its second quarter ended June 30, 2026. Recent Highlights • Reported second quarter 2026 revenue was $3.6 million, up 10% year over year. • CapsoCam Plus® used by over 176,000 patients as of June 30, 2026. • Launched AI Highlights™, the AI-assisted reading feature for CapsoCam Plus®, commercially in the European Union and other international markets to support physician review of small bowel capsule endoscopy studies using the CapsoCam Plus® system. • Anticipate FDA clearance of AI Highlights™ by the end of the...
Source
Exhibit EX-99.1
0001378325-26-000035
Filed August 13, 2026 at 8:07 PM UTC. The figures above are from the audited statements, not from this release.